These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30577702)

  • 21. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perampanel: as adjunctive therapy in patients with partial-onset seizures.
    Plosker GL
    CNS Drugs; 2012 Dec; 26(12):1085-96. PubMed ID: 23179642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, exposure-cognition, and exposure-efficacy relationships of perampanel in adolescents with inadequately controlled partial-onset seizures.
    Villanueva V; Majid O; Nabangchang C; Yang H; Laurenza A; Ferry J; Hussein Z
    Epilepsy Res; 2016 Nov; 127():126-134. PubMed ID: 27595590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies.
    Rektor I; Krauss GL; Inoue Y; Kaneko S; Williams B; Patten A; Malhotra M; Laurenza A; Wechsler RT
    Epilepsia; 2020 Jul; 61(7):1491-1502. PubMed ID: 32645213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life in pediatric patients with partial onset seizures or primary generalized tonic-clonic seizures receiving adjunctive perampanel.
    Trigg A; Brohan E; Cocks K; Jones A; Tahami Monfared AA; Chabot I; Meier G; Campbell R; Li H; Ngo LY
    Epilepsy Behav; 2021 May; 118():107938. PubMed ID: 33839450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters.
    Gidal BE; Maganti R; Laurenza A; Yang H; Verbel DA; Schuck E; Ferry J
    Epilepsy Res; 2017 Aug; 134():41-48. PubMed ID: 28535410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel treatment options for epilepsy: focus on perampanel.
    Franco V; Crema F; Iudice A; Zaccara G; Grillo E
    Pharmacol Res; 2013 Apr; 70(1):35-40. PubMed ID: 23287426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures.
    Fogarasi A; Flamini R; Milh M; Phillips S; Yoshitomi S; Patten A; Takase T; Laurenza A; Ngo LY
    Epilepsia; 2020 Jan; 61(1):125-137. PubMed ID: 31912493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and adverse effects of established and new antiepileptic drugs.
    Mattson RH
    Epilepsia; 1995; 36 Suppl 2():S13-26. PubMed ID: 8784211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON).
    Abril Jaramillo J; Estévez María JC; Girón Úbeda JM; Vega López Ó; Calzado Rivas ME; Pérez Díaz H; García Martín G; Vila Herrero E; Chamorro-Muñoz M; Vázquez F; De la Fuente C; Redondo L; Peláez N; Santágueda P; Rodríguez Uranga JJ
    Epilepsy Behav; 2020 Jan; 102():106655. PubMed ID: 31812902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Perampanel in the treatment of patients with epilepsy].
    Rider FK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9. Vyp. 2):63-69. PubMed ID: 29213041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials.
    Majid O; Laurenza A; Ferry J; Hussein Z
    Br J Clin Pharmacol; 2016 Aug; 82(2):422-30. PubMed ID: 27038098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsy.
    Gidal BE; Laurenza A; Hussein Z; Yang H; Fain R; Edelstein J; Kumar D; Ferry J
    Neurology; 2015 May; 84(19):1972-80. PubMed ID: 25878177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perampanel Serum Concentrations in Adults With Epilepsy: Effect of Dose, Age, Sex, and Concomitant Anti-Epileptic Drugs.
    Patsalos PN; Gougoulaki M; Sander JW
    Ther Drug Monit; 2016 Jun; 38(3):358-64. PubMed ID: 26727625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective audit with adjunctive perampanel: Preliminary observations in focal epilepsy.
    Brodie MJ; Stephen LJ
    Epilepsy Behav; 2016 Jan; 54():100-3. PubMed ID: 26700063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year clinical experience of perampanel in Spain: a multicentre study of efficacy and tolerability.
    Garamendi-Ruiz I; García-García ME; Bertol-Alegre V; Mauri-Llerda JÁ; García-Morales I; Garayoa-Irigoyen V; Agúndez-Sarasola M; De Toledo-Heras M; García-Morales V; García-Gomara MJ; Arcos-Sánchez C; Gago-Veiga A; Escalza-Cortina I; Rueda-Mena E; Muñoz-Fargas E; Santos-Lasaosa S; Oliván-Usieto JA; Julián LD; Gómez-Esteban JC; Marinas-Alejo A
    Epileptic Disord; 2016 Jun; 18(2):173-80. PubMed ID: 27238234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lacosamide for the treatment of epilepsy.
    de Biase S; Gigli GL; Valente M; Merlino G
    Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):459-68. PubMed ID: 24479852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic and pharmacokinetic interactions of perampanel and other antiepileptic drugs in a rat amygdala kindling model.
    Wu T; Nagaya Y; Hanada T
    Seizure; 2014 Oct; 23(9):732-9. PubMed ID: 24997072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization.
    Trinka E; Tsong W; Toupin S; Patten A; Wilson K; Isojarvi J; James D
    Epilepsy Res; 2020 Oct; 166():106403. PubMed ID: 32673969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
    Wellington K; Goa KL
    CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.